Inflammatory bowel disease management - Some thoughts on future drug developments

被引:13
作者
Rhodes, J [1 ]
Thomas, G [1 ]
Evans, BK [1 ]
机构
[1] S GLAMORGAN HLTH AUTHOR, CARDIFF, S GLAM, WALES
关键词
D O I
10.2165/00003495-199753020-00001
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
This article is intended to stimulate thought and focus on those areas where we feel advances in drug therapy for inflammatory bowel disease may occur. It is not an extensive review of current practice, although this is considered where it is thought to be pertinent to future developments. There are several excellent reviews of current practice which we do not attempt to repeat, nor do we give a comprehensive set of references, but cite well referenced reviews where necessary. New therapeutic developments should ideally stem from an understanding of the cause or pathogenesis of a condition; alternatively, established therapies may be modified or used as a basis for progress. Since the causes of both ulcerative colitis and Crohn's disease remain unknown, most forward thinking on drug development must come from current practice, but remain open to novel approaches. Our thoughts on possible future treatments for inflammatory bowel disease are somewhat selective, and because of their speculative nature are unlikely to coincide with those of others - only the future will reveal genuine advances as they become incorporated into established practice.
引用
收藏
页码:189 / 194
页数:6
相关论文
共 36 条
[1]  
AZADKHAN AK, 1977, LANCET, V2, P892
[2]  
BELL CJ, IN PRESS BIODRUGS
[3]   Effect of an enteric-coated fish-oil preparation on relapses in Crohn's disease [J].
Belluzzi, A ;
Brignola, C ;
Campieri, M ;
Pera, A ;
Boschi, S ;
Miglioli, M .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (24) :1557-1560
[4]  
BJORCK S, 1992, AGENTS ACTIONS, pC60
[5]   STUDIES OF 2 NOVEL SULFASALAZINE ANALOGS, IPSALAZIDE AND BALSALAZIDE [J].
CHAN, RP ;
POPE, DJ ;
GILBERT, AP ;
SACRA, PJ ;
BARON, JH ;
LENNARDJONES, JE .
DIGESTIVE DISEASES AND SCIENCES, 1983, 28 (07) :609-615
[6]   TREATMENT OF INFLAMMATORY BOWEL-DISEASE FROM NOW TO THE MILLENNIUM [J].
COLE, AT ;
HAWKEY, CJ .
BAILLIERES CLINICAL GASTROENTEROLOGY, 1994, 8 (02) :351-379
[7]  
DEKASKI MC, 1993, ALIMENT PHARM THERAP, V7, P567
[8]   AN ORAL PREPARATION TO RELEASE DRUGS IN THE HUMAN-COLON [J].
DEW, MJ ;
HUGHES, PJ ;
LEE, MG ;
EVANS, BK ;
RHODES, J .
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 1982, 14 (03) :405-408
[9]  
DJIMBO M, 1984, J PHARM BELG, V39, P36
[10]   Oral budesonide as maintenance treatment for Crohn's disease: A placebo-controlled, dose-ranging study [J].
Greenberg, GR ;
Feagan, BG ;
Martin, F ;
Sutherland, LR ;
Thomson, ABR ;
Williams, N ;
Nilsson, LG ;
Persson, T .
GASTROENTEROLOGY, 1996, 110 (01) :45-51